WhitTier Trust Company’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-232
Closed -$6.27K – 1232
2023
Q4
$6.27K Sell
232
-5
-2% -$131 ﹤0.01% 1000
2023
Q3
$7.02K Hold
237
– – ﹤0.01% 951
2023
Q2
$8.48K Hold
237
– – ﹤0.01% 976
2023
Q1
$5.55K Hold
237
– – ﹤0.01% 1013
2022
Q4
$6.44K Hold
237
– – ﹤0.01% 1002
2022
Q3
$13K Sell
237
-2
-0.8% -$103 ﹤0.01% 876
2022
Q2
$10K Hold
239
– – ﹤0.01% 918
2022
Q1
$16K Hold
239
– – ﹤0.01% 847
2021
Q4
$24K Buy
239
+164
+219% +$17K ﹤0.01% 780
2021
Q3
$9K Buy
+75
New +$8.91K ﹤0.01% 943

Other funds holding GH

WhitTier Trust Company's GH Position: Q1 2024 in Review

WhitTier Trust Company sold out of Guardant Health (GH) in Q1 2024, closing a stake of 232 shares — an estimated $6.27K sold.

WhitTier Trust Company first reported a position in GH in Q3 2021 and held it in 10 quarters. The position peaked at $24K in Q4 2021. 258 funds tracked by Wall St. Rank hold GH as of Q1 2024.

  • WhitTier Trust Company reported no remaining Guardant Health position as of Q1 2024 after selling out during the quarter.
  • WhitTier Trust Company sold 232 Guardant Health shares in Q1 2024, an estimated $6.27K.
  • WhitTier Trust Company first reported a position in Guardant Health in Q3 2021 and held it in 10 quarters.
  • WhitTier Trust Company's Guardant Health position peaked at $24K in Q4 2021.
  • 258 funds tracked by Wall St. Rank held Guardant Health as of Q1 2024.

Based on WhitTier Trust Company's 13F filing for Q1 2024, filed 2 May 2024.